Schizophrenia Susceptibility Genes and Neurodevelopment

Biological Psychiatry

Volumn 61, Issue 10, 2007, Pages 1119-1120

  Harrison, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CANNABIS; CATECHOL METHYLTRANSFERASE; CYTOSKELETON PROTEIN; GLUTAMATE RECEPTOR 3; NEU DIFFERENTIATION FACTOR; PROTEIN DISC1; PROTEIN DYSBINDIN; UNCLASSIFIED DRUG;

BRAIN MATURATION; CELL MIGRATION; CLINICAL TRIAL; COGNITIVE DEFECT; DNA POLYMORPHISM; EDITORIAL; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC MANIPULATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VELOCARDIOFACIAL SYNDROME; WORKING MEMORY;

ADULT; BRAIN; CATECHOL O-METHYLTRANSFERASE; CHILD; DIGEORGE SYNDROME; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NERVE TISSUE PROTEINS; SCHIZOPHRENIA;

EID: 34247631186     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.02.021     Document Type: Editorial

References (14)

1. Arguello P.A., and Gogos J.A. Modeling madness in mice: One piece at a time. Neuron 52 (2006) 179-196
2. Arnold S.E., Talbot K., and Hahn C.-G. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 147 (2005) 319-345
3. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., and Jones P.B. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 164 (2007) 142-149
4. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H.L., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene x environment interaction. Biol Psychiatry 57 (2005) 1117-1127
5. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7 (2004) 575-580
6. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9 (2006) 1477-1478
7. Harrison P.J., and Law A.J. Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology. Biol Psychiatry 60 (2006) 132-140
8. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression and neuropathology: On the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
9. Jones P., and Murray R.M. The genetics of schizophrenia is the genetics of neurodevelopment. Br J Psychiatry 158 (1991) 615-623
10. Law A.J., Lipska B.K., Weickert C.S., Hyde T.M., Straub R.E., Hashimoto R., et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A 103 (2006) 6747-6752
11. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Ann Rev Neurosci 25 (2002) 409-432
12. Sei Y., Patterson R.R., Li Z., Tunbridge E.M., Egan M.F., Kolachana B.S., and Weinberger D.R. Neuregulin-1 induced cell migration is impaired in schizophrenia: Association with neuregulin 1 and catechol-o-methyltransferase gene polymorphisms. Mol Psychiatry (2007) (in press)
13. 158Met and beyond. Biol Psychiatry 60 (2006) 141-151
14. Tunbridge E.M., Weickert C.S., Kleinman J.E., Herman M.M., Chen J., Kolachana B.S., et al. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 17 (2007) 1706-1712